Hypothalamus-pituitary-thyroid axis disruption in rats with breast cancer is related to an altered endogenous oxytocin/insulin-regulated aminopeptidase (IRAP) system

Tumor Biology

Volumn 32, Issue 3, 2011, Pages 543-549

  Carrera González, María Pilar ^a   Ramírez Expósito, María Jesús ^a   De Saavedra, Jose Manuel Arias ^b   Sánchez Agesta, Rafael ^b   Mayas, María Dolores ^a   Martínez Martos, Jose Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b Servicio de Medicina Interna   (Spain)

Author keywords

Breast cancer; Free thyroxine; N Methyl nitrosourea; Oxytocin; Oxytocinase; Thyroid; Thyroid stimulating hormone

Indexed keywords

AMINOPEPTIDASE; CYSTYL AMINOPEPTIDASE; INSULIN; OXYTOCIN; THYROTROPIN; THYROXINE; LEUCYL CYSTINYL AMINOPEPTIDASE; LEUCYL-CYSTINYL AMINOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CATABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID DISEASE; THYROID FUNCTION; UPREGULATION; ANIMAL; BLOOD; EXPERIMENTAL NEOPLASM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; THYROID GLAND; WISTAR RAT;

ANIMALS; CYSTINYL AMINOPEPTIDASE; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAMMARY NEOPLASMS, EXPERIMENTAL; OXYTOCIN; RATS; RATS, WISTAR; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 79960585074     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0149-y     Document Type: Article

References (38)

1. Michalaki V, Kondi-Pafiti A, Gennatas S, Antoniou A, Primetis H, Gennatas C. Breast cancer in association with thyroid disorders. J BUON. 2009;14(3):425-8.
2. Smyth PP, Smith DF, McDermott EW, Murray MJ, Geraghty JG, O'Higgins NJ. A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab. 1996;81:937-41. (Pubitemid 26083950)
3. Shering SG, Zbar AP, Moriarty M, McDermot EW, O'Higgins NJ, Smyth PP. Thyroid disorders and breast cancer. Eur J Cancer Prev. 1996;5:504-6. (Pubitemid 27087376)
4. Giani C, Fierabracci P, Bonacci R, Gigliotti A, Campani D, De Negri F, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab. 1996;81:990-4. (Pubitemid 26083958)
5. Smyth PP. The thyroid and breast cancer: a significant association? Ann Med. 1997;29:189-91. (Pubitemid 27292526)
6. Smyth PP, Shering SG, Kilbane MT, Murray MJ, McDermott EW, Smith DF, et al. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab. 1998;83:2711-6. (Pubitemid 28493765)
7. Smyth PP. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors. 2003;19:121-30. (Pubitemid 38175115)
8. Smyth PP. The thyroid, iodine and breast cancer. Breast Cancer Res. 2003;5:235-8. (Pubitemid 37080851)
9. Kuijpens JL, Nyklictek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid. 2005;15:1253-9. (Pubitemid 41821759)
10. Finley JW, Bogardus GM. Breast cancer and thyroid disease. Q Rev Surg Obstet Gynecol. 1960;17:139-47.
11. Adamopoulos DA, Vassilaros S, Kapolla N, Papadiamantis J, Georgiakodis F, Michalakis A. Thyroid disease in patients with benign and malignant mastopathy. Cancer. 1986;57:125-8. (Pubitemid 16212246)
12. Smyth PP. Autoimmune thyroid disease and breast cancer: a chance association? J Endocrinol Invest. 2000;23(1):42-3. (Pubitemid 30105319)
13. Maruchi N, Annegers JF, Kurland LT. Hashimoto's thyroiditis and breast cancer. Mayo Clin Proc. 1976;51:263-5.
14. Larsen PR, Davies TF. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, editors. Textbook of endocrinology. Philadelphia: Saunders; 1998.
15. Frawley LS, Leong DA, Neill JD. Oxytocin attenuates TRH-induced TSH release from rat pituitary cells. Neuroendocrinology. 1985;40:201-4. (Pubitemid 15125632)
16. Petersson M. Oxytocin decreases plasma levels of thyroid-stimulating hormone and thyroid hormones in rats. Regul Pept. 2002;108:83-7. (Pubitemid 35239863)
17. Raggenbass M. Vasopressin-and oxytocin-induced activity in the central nervous system: electrophysiological studies using in-vitro systems. Prog Neurobiol. 2001;64(3):307-26. (Pubitemid 32193784)
18. Tsujimoto M, Mizutani S, Adachi H, Kimura M, Nakazato H, Tomoda Y. Identification of human placental leucine aminopep-tidase as oxytocinase. Arch Biochem Biophys. 1992;292:388-92.
19. Mizutani S, Sumi S, Oka K, Yamada R, Kurauchi O, Taira H, et al. In vitro degradation of oxytocin by pregnancy serum, placental subcellular fractions and purified placental aminopeptidases. Exp Clin Endocrinol. 1985;86:310-6. (Pubitemid 16180002)
20. Martinez JM, Prieto I, Ramirez MJ, Cueva C, Alba F, Ramirez M. Aminopeptidase activities in breast cancer tissue. Clin Chem. 1999;45:1797-802. (Pubitemid 29477338)
21. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Garcia MJ, Mayas MD, Martinez-Martos JM. Serum oxytocinase activity is related to tumour growth parameters in N-methyl nitrosourea induced rat breast cancer. Life Sci. 2004;75:1369-77. (Pubitemid 38845035)
22. Rivera ES, Andrade N, Martin G, Melito G, Cricco G, Mohamad N, et al. Induction of mammary tumours in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. Cancer Lett. 1994;86:223-8. (Pubitemid 24340537)
23. Gago-Dominguez M, Castelao JE. Role of lipid peroxidation and oxidative stress in the association between thyroid diseases and breast cancer. Crit Rev Oncol Hematol. 2008;68:107-14.
24. Makina DM, Krasnovskaia IA. Inhibitory effect of noradrenaline on thyrostimulating activity of oxytocin in rats. Biull Eksp Biol Med. 1999;128:657-9.
25. Makina DM, Krasnovskaia IA. Morphofunctional characteristics of rat thyroid gland under the combined effect of oxytocin and adrenaline. Morfologiia. 1999;115:34-7.
26. Turken O, NarIn Y, DemIrbas S, Onde ME, Sayan O, KandemIr EG, et al. Breast cancer in association with thyroid disorders. Breast Cancer Res. 2003;5:R110-3.
27. Ron E, Curtis R, Hoffman DA, Flannery JT. Multiple primary breast and thyroid cancer. Br J Cancer. 1984;49:87-92. (Pubitemid 14194031)
28. Dumont JE, Maenhaut C, Pirson I, Baptist M, Roger PP. Growth factors controlling the thyroid gland. Baillières Clin Endocrinol Metab. 1991;5:727-54.
29. Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Malm J, Manjer J. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. Breast Cancer Res. 2010;12(3):R33.
30. Martinez JM, Ramirez MJ, Prieto I, Alba F, Ramirez M. Sex differences and in vitro effects of steroids on serum aminopepti-dase activities. Peptides. 1998;19:1637-40. (Pubitemid 29015905)
31. Garcia MJ, Martinez-Martos JM, Mayas MD, Carrera MP, De la Chica S, Cortes P, et al. Hormonal status modifies renin-angiotensin system-regulating aminopeptidases and vasopressin-degrading activity in the hypothalamus- pituitary-adrenal axis of female mice. Med Chem. 2008;4:336-47.
32. Carrera MP, Ramirez-Exposito MJ, Garcia MJ, Mayas MD, Martinez-Martos JM (2008) Ovarian renin-angiotensin system is involved in progesterone overproduction in rats with mammary tumours induced by n-methyl nitrosourea (NMU). ASEICA S1
33. Koohi MK, Ivell R, Walther N. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action. J Neuroendocrinol. 2005;17(4):197-207. (Pubitemid 40585267)
34. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Garcia MJ, Mayas MD, Arias de Saavedra JM, et al. Pyrrolidon carboxypep-tidase activities in the hypothalamus-pituitary-thyroid and hypothalamus-pituitary-ovary axes of rats with mammary gland cancer induced by N-methyl nitrosourea. Horm Metab Res. 2005;37:74-8. (Pubitemid 40445126)
35. Cassoni P, Marrocco T, Sapino A, Allia E, Bussolati G. Oxytocin synthesis within the normal and neoplastic breast: first evidence of a local peptide source. Int J Oncol. 2006;28(5):1263-8.
36. Cassoni P, Sapino A, Marrocco T, Chini B, Bussolati G. Oxytocin and oxytocin receptors in cancer cells and proliferation. J Neuroendocrinol. 2004;16(4):362-4. (Pubitemid 38618654)
37. Cassoni P, Marrocco T, Deaglio S, Sapino A, Bussolati G. Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumours. Ann Oncol. 2001;12:S37-9. (Pubitemid 33069685)
38. Carrera MP, Ramirez-Exposito MJ, Martinez-Martos JM. Actual and potential agents and biomarkers in the treatment of cancer. Anticancer Agents Med Chem. 2009;9:500-16.